InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results
InspireMD (NSPR), developer of the CGuard™ Prime carotid stent system for treating carotid artery disease and stroke prevention, has scheduled its fourth quarter and full year 2024 financial results announcement for March 12, 2025.
The company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss financial results and recent highlights. Investors can join via phone (domestic: 1-800-579-2543, international: 1-785-424-1789) or through the company's investor relations website.
InspireMD (NSPR), sviluppatore del sistema di stent carotideo CGuard™ Prime per il trattamento della malattia carotidea e la prevenzione degli ictus, ha programmato l'annuncio dei suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 per il 12 marzo 2025.
L'azienda ospiterà una conferenza telefonica e un webcast alle 8:30 a.m. Eastern Time per discutere i risultati finanziari e i recenti punti salienti. Gli investitori possono partecipare tramite telefono (nazionale: 1-800-579-2543, internazionale: 1-785-424-1789) o attraverso il sito web delle relazioni con gli investitori dell'azienda.
InspireMD (NSPR), desarrollador del sistema de stent carotídeo CGuard™ Prime para el tratamiento de la enfermedad carotídea y la prevención de accidentes cerebrovasculares, ha programado el anuncio de sus resultados financieros del cuarto trimestre y del año completo 2024 para el 12 de marzo de 2025.
La compañía llevará a cabo una conferencia telefónica y una transmisión web a las 8:30 a.m. hora del Este para discutir los resultados financieros y los aspectos destacados recientes. Los inversores pueden unirse por teléfono (nacional: 1-800-579-2543, internacional: 1-785-424-1789) o a través del sitio web de relaciones con inversores de la compañía.
InspireMD (NSPR)는 경동맥 질환 치료 및 뇌졸중 예방을 위한 CGuard™ Prime 경동맥 스텐트 시스템의 개발업체로, 2024년 4분기 및 전체 연간 재무 결과 발표를 2025년 3월 12일로 예정하였습니다.
회사는 동부 표준시 기준 오전 8시 30분에 재무 결과 및 최근 주요 사항을 논의하기 위한 전화 회의 및 웹캐스트를 개최할 것입니다. 투자자는 전화(국내: 1-800-579-2543, 국제: 1-785-424-1789) 또는 회사의 투자자 관계 웹사이트를 통해 참여할 수 있습니다.
InspireMD (NSPR), développeur du système de stent carotidien CGuard™ Prime pour le traitement des maladies carotidiennes et la prévention des AVC, a prévu d'annoncer ses résultats financiers du quatrième trimestre et de l'année entière 2024 pour le 12 mars 2025.
L'entreprise organisera une conférence téléphonique et un webinaire à 8h30, heure de l'Est, pour discuter des résultats financiers et des points saillants récents. Les investisseurs peuvent participer par téléphone (national : 1-800-579-2543, international : 1-785-424-1789) ou via le site Web des relations avec les investisseurs de l'entreprise.
InspireMD (NSPR), Entwickler des CGuard™ Prime Carotisstentsystems zur Behandlung von Carotisarterienerkrankungen und zur Schlaganfallprävention, hat die Bekanntgabe seiner Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 für den 12. März 2025 angesetzt.
Das Unternehmen wird um 8:30 Uhr Eastern Time eine Telefonkonferenz und einen Webcast abhalten, um die Finanzergebnisse und aktuelle Highlights zu besprechen. Investoren können telefonisch (national: 1-800-579-2543, international: 1-785-424-1789) oder über die Investor-Relations-Website des Unternehmens teilnehmen.
- None.
- None.
MIAMI, Feb. 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced that it will release its fourth quarter and full year 2024 financial results on Wednesday, March 12, 2025. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights.
Interested parties may access the live earnings call via telephone by dialing 1-800-579-2543 for domestic callers or 1-785-424-1789 for international callers. The live webinar may be accessed by visiting the Events Section of the InspireMD investor relations website or by registering below. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on InspireMD’s website.
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1710071&tp_key=533cb06aa3
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free, long-term outcomes. InspireMD’s common stock is quoted on the Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Investor Contact:
Craig Shore
Chief Financial Officer
InspireMD, Inc.
888-776-6804
craigs@inspiremd.com
Webb Campbell
Gilmartin Group LLC
Webb@gilmartinir.com
investor-relations@inspiremd.com
FAQ
When will InspireMD (NSPR) release its Q4 and full year 2024 earnings?
How can investors join InspireMD's Q4 2024 earnings call?
What is InspireMD's main product offering?
Will InspireMD's Q4 2024 earnings call be available for replay?
